Literature DB >> 2690014

'Sticky feet'-directed mutagenesis and its application to swapping antibody domains.

T Clackson1, G Winter.   

Abstract

We describe a novel technique for precisely cutting and pasting two DNA sequences without using restriction sites. The method is based on site-directed mutagenesis and uses a long primer, generated by the polymerase chain reaction (PCR), to transfer large segments of DNA into a single-stranded template. The primer anneals to the template by virtue of 'sticky feet' sequences (complementary to the template) which are introduced at the ends of the primer by the PCR. Yields of desired recombinants were high (approximately 36%) and the transplanted sequences (approximately 400bp) free of errors. We have used this technique to swap CH2 domains between two mouse antibodies, and find that this domain can carry features critical for triggering complement lysis, in addition to the C1q binding motif.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2690014      PMCID: PMC335290          DOI: 10.1093/nar/17.24.10163

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  27 in total

1.  Cloning and complete nucleotide sequence of mouse immunoglobulin gamma 1 chain gene.

Authors:  T Honjo; M Obata; Y Yamawaki-Katoaka; T Kataoka; T Kawakami; N Takahashi; Y Mano
Journal:  Cell       Date:  1979-10       Impact factor: 41.582

2.  A simple method for site-directed mutagenesis using the polymerase chain reaction.

Authors:  A Hemsley; N Arnheim; M D Toney; G Cortopassi; D J Galas
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

3.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

Authors:  R M Horton; H D Hunt; S N Ho; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

4.  Chemical verification of the C1q receptor site on IgG.

Authors:  E J Emanuel; A D Brampton; J Gagnon; R A Dwek
Journal:  FEBS Lett       Date:  1982-01-25       Impact factor: 4.124

5.  The Clq receptor site on immunoglobulin G.

Authors:  D R Burton; J Boyd; A D Brampton; S B Easterbrook-Smith; E J Emanuel; J Novotny; T W Rademacher; M R van Schravendijk; M J Sternberg; R A Dwek
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

6.  The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement.

Authors:  D E Isenman; K J Dorrington; R H Painter
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

7.  Activation of mouse complement by monoclonal mouse antibodies.

Authors:  M S Neuberger; K Rajewsky
Journal:  Eur J Immunol       Date:  1981-12       Impact factor: 5.532

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA.

Authors:  M J Zoller; M Smith
Journal:  Nucleic Acids Res       Date:  1982-10-25       Impact factor: 16.971

View more
  13 in total

1.  Two bipartite NLSs mediate constitutive nuclear localization of Mcm10.

Authors:  Rebekah Burich; Ming Lei
Journal:  Curr Genet       Date:  2003-09-10       Impact factor: 3.886

2.  Alternative splicing of a human alpha-tropomyosin muscle-specific exon: identification of determining sequences.

Authors:  I R Graham; M Hamshere; I C Eperon
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

3.  Construction of in-frame chimeric plant viral genes by simplified PCR strategies.

Authors:  C D Atreya; P L Atreya; T P Pirone
Journal:  Plant Mol Biol       Date:  1992-06       Impact factor: 4.076

4.  Elements regulating an alternatively spliced exon of the rat fibronectin gene.

Authors:  G S Huh; R O Hynes
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

5.  Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.

Authors:  N A Cacalano; T S Migone; F Bazan; E P Hanson; M Chen; F Candotti; J J O'Shea; J A Johnston
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

6.  Incompatibility of connexin 40 and 43 Hemichannels in gap junctions between mammalian cells is determined by intracellular domains.

Authors:  S Haubrich; H J Schwarz; F Bukauskas; H Lichtenberg-Fraté; O Traub; R Weingart; K Willecke
Journal:  Mol Biol Cell       Date:  1996-12       Impact factor: 4.138

7.  Splice-junction elements and intronic sequences regulate alternative splicing of the Drosophila myosin heavy chain gene transcript.

Authors:  D M Standiford; M B Davis; W Sun; C P Emerson
Journal:  Genetics       Date:  1997-10       Impact factor: 4.562

8.  Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032).

Authors:  Fiona McPhee; Amy K Sheaffer; Jacques Friborg; Dennis Hernandez; Paul Falk; Guangzhi Zhai; Steven Levine; Susan Chaniewski; Fei Yu; Diana Barry; Chaoqun Chen; Min S Lee; Kathy Mosure; Li-Qiang Sun; Michael Sinz; Nicholas A Meanwell; Richard J Colonno; Jay Knipe; Paul Scola
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

9.  Gene dose-dependent maturation and receptor editing of B cells expressing immunoglobulin (Ig)G1 or IgM/IgG1 tail antigen receptors.

Authors:  S L Pogue; C C Goodnow
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

10.  Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation.

Authors:  M H Tao; R I Smith; S L Morrison
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.